menu
    • menu
    [{"orgOrder":0,"company":"FibroBiologics","sponsor":"Charles River Laboratories, Inc","pharmaFlowCategory":"D","therapeuticArea":"Podiatry","country":"U.S.A","productType":"Cell and Gene therapy","year":"2024","type":"Collaboration","leadProduct":"CYWC628","moa":"","graph1":"Podiatry","graph2":"Preclinical","graph3":"FibroBiologics","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Podiatry","amount2New":0,"dosageForm":"","sponsorNew":"FibroBiologics \/ FibroBiologics","highestDevelopmentStatusID":"4","companyTruncated":"FibroBiologics \/ FibroBiologics"},{"orgOrder":0,"company":"FibroBiologics","sponsor":"Yorkville","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"","productType":"Cell and Gene therapy","year":"2024","type":"Financing","leadProduct":"CYPS317","moa":"","graph1":"Dermatology","graph2":"Preclinical","graph3":"FibroBiologics","amount2":0.029999999999999999,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Dermatology","amount2New":0.029999999999999999,"dosageForm":"","sponsorNew":"FibroBiologics \/ Yorkville","highestDevelopmentStatusID":"4","companyTruncated":"FibroBiologics \/ Yorkville"}]

    Find Clinical Drug Pipeline Developments & Deals by FibroBiologics

    Menu

    FibroBiologics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            FibroBiologics

                            U.S.A arrow
                            AAM
                            Not Confirmed

                            FibroBiologics

                            U.S.A arrow
                            AAM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : CYPS317

                            Therapeutic Area : Dermatology

                            Study Phase : Preclinical

                            Sponsor : Yorkville

                            Deal Size : $25.0 million

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            FibroBiologics Announces $25 Million Financing

                            Details : The financing is intended to support the clinical development of CYPS317, currently being evaluated for the treatment of psoriasis.

                            Product Name : Undisclosed

                            Product Type : Cell and Gene therapy

                            Upfront Cash : Undisclosed

                            December 23, 2024

                            Lead Product(s) : CYPS317

                            Therapeutic Area : Dermatology

                            Highest Development Status : Preclinical

                            Sponsor : Yorkville

                            Deal Size : $25.0 million

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            FibroBiologics

                            U.S.A arrow
                            AAM
                            Not Confirmed

                            FibroBiologics

                            U.S.A arrow
                            AAM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : CYWC628

                            Therapeutic Area : Podiatry

                            Study Phase : Preclinical

                            Recipient : Charles River Laboratories, Inc

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            FibroBiologics and Charles River Partner for Fibroblast Cell-Based Therapies

                            Details : The collaboration aims to develop and manufacture FibroBiologics’ therapeutic master cell bank, working cell bank, and fibroblast-based spheroids product, CYWC628, for diabetic foot ulcer (DFU).

                            Product Name : CYWC628

                            Product Type : Cell and Gene therapy

                            Upfront Cash : Undisclosed

                            October 18, 2024

                            Lead Product(s) : CYWC628

                            Therapeutic Area : Podiatry

                            Highest Development Status : Preclinical

                            Recipient : Charles River Laboratories, Inc

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth